Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations
Human Gene Therapy · 2025-03 · 36 (5-6) · 597-617
DOI: 10.1089/hum.2024.191 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Gene Therapy, online erschienen am 06.03.2025. Verfasst von Sachin Chaugule und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA. Hauptthemen laut MEDLINE: Osteogenesis Imperfecta, Genetic Therapy. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Osteogenesis imperfecta (OI) is a rare genetic disorder characterized by bone fragility due to reduced bone quality, often accompanied by low bone mass, recurrent fractures, hearing loss, skeletal abnormalities, and short stature. Pathogenic variants in over 20 genes lead to clinical and genetic variability in OI, resulting in diverse symptoms and severity. Current management involves a multidisciplinary approach, including antiresorptive medications, physiotherapy, occupational therapy, and orthopedic surgery, which provide symptomatic relief but no cure. Advancements in gene therapy technologies and stem cell therapies offer promising prospects for long-lasting or permanent solutions. This review provides a comprehensive overview of OI’s classification, pathogenesis, and current treatment options. It also explores emerging biotechnologies for stem cells and gene-targeted therapies in OI. The potential of these innovative therapies and their clinical implementation challenges are evaluated, focusing on their imminent success in treating bone disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
- Department of Genetic and Cellular Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
- Horae Gene Therapy Center, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
- Department of Human Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam; Amsterdam Rare Bone Disease center, Amsterdam Bone Center, Amsterdam Movement Sciences, Amsterdam Reproduction and Development, Amsterdam, The N…
- Department of Internal Medicine, Section Endocrinology & Metabolism, Amsterdam UMC, Vrije Universiteit Amsterdam; Amsterdam Rare Bone Disease center, Amsterdam Bone Center, Amsterdam Movement Sciences, Amsterdam Reprodu…
- Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Sachin Chaugule, Marelise Eekhoff, Jae-Hyuck Shim
Zitieren
APA
Chaugule, S., Constantinou, C. K., John, A. A., Micha, D., Eekhoff, M., Gravallese, E., Gao, G., & Shim, J. H. (2025). Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations. Human Gene Therapy, 36(5-6), 597-617. https://doi.org/10.1089/hum.2024.191
Vancouver
Chaugule S, Constantinou CK, John AA, Micha D, Eekhoff M, Gravallese E, et al. Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations. Human Gene Therapy. 2025;36(5-6):597-617. doi:10.1089/hum.2024.191
BibTeX
@article{Chaugule2025,
author = {Chaugule, Sachin and Constantinou, Christodoulos Kypros and John, Aijaz Ahmad and Micha, Dimitra and Eekhoff, Marelise and Gravallese, Ellen and Gao, Guangping and Shim, Jae-Hyuck},
title = {Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations},
journal = {Human Gene Therapy},
year = {2025},
volume = {36},
number = {5-6},
pages = {597--617},
doi = {10.1089/hum.2024.191}
}
EUVIMED